四川双马(000935) - 2024 Q4 - 年度业绩预告

Financial Performance - The company expects a net profit attributable to shareholders of between 280 million and 380 million CNY, representing a decline of 61.44% to 71.59% compared to the previous year's profit of 985.47 million CNY[3] - The net profit after deducting non-recurring gains and losses is projected to be between 240 million and 340 million CNY, down 63.78% to 74.43% from last year's 938.71 million CNY[3] - Basic earnings per share are estimated to be between 0.37 CNY and 0.50 CNY, a decrease from 1.29 CNY in the previous year[3] Market Challenges - The decline in performance is attributed to fluctuations in the capital market affecting the fair value of investment projects, and a slow recovery in market demand for building materials in the first three quarters[6] - The overall sales volume and prices in the building materials sector have significantly declined compared to the previous year, despite some recovery in the fourth quarter due to supportive government policies[6] Strategic Initiatives - Despite the challenges, the company is taking measures to optimize operational efficiency and control costs, including seeking alternative raw materials and strict cash flow management[6] - The company has successfully acquired Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd., which is expected to provide a solid foundation for future growth[6] - The company is actively working on fundraising for the Yibin Harmony Green Industry Development Equity Investment Partnership, which is expected to increase management fee income[6] Caution for Investors - Investors are advised to exercise caution and be aware of investment risks as the company continues to navigate these challenges[7] - The financial data presented is preliminary and has not been audited by registered accountants, with detailed financial results to be disclosed in the 2024 annual report[4][7]